Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
10,994 total articles
Canadian National (CNI) reported a clean Q2 with double-digit EPS growth, raised guidance, and announced a quarterly dividend that keeps income-oriented buyers interested. Regulatory developments that slow a large U.S. rail merger and a new BHP potash logistics win reduce competitive risk. Technically, CN sits above its key moving averages with bul…
HealthEquity (HQY) has shown durable earnings momentum and balance-sheet-driven growth in HSAs and invested assets. With HSA assets at $36.5B, investments up 26% year-over-year and free cash flow near $457M, the company is executing. Valuation is full but not extreme: market cap roughly $7.9B and a P/E around 34x. For traders willing to accept shor…
AXT has moved from obscure to indispensable as indium phosphide wafers become a bottleneck for AI optics. The company’s revenue cadence and capacity moves argue for a near-term beat; the stock already prices a perfect outcome. I recommend a tactical long ahead of Q2 with a strict stop to manage the stretched valuation and execution risk.
ServiceNow is trading well below its 52-week high despite accelerating revenue and strong free cash flow. The stock's high multiple reflects AI-driven growth expectations; this trade targets a disciplined entry at $99.50 with a $130 target over 180 trading days and a $90 stop, balancing upside from product-led AI adoption with valuation risk and ne…
Allied Gold (AAUC) is trading well below levels justified by the combination of an advanced takeover process and improving operational metrics. With key regulatory clearances recently received and the outside date extended to 07/29/2026, the market has priced in an outsized chance of deal failure. That over-discount creates a high-probability, mid-…
Kinder Morgan offers a reliable 3.6%-3.8% yield, $3.16B in free cash flow and conservative balance sheet metrics that support a tactical long on weakness. Valuation is reasonable for a midstream operator (EV/EBITDA ~9.9) and the company has a $9.6B backlog plus $10B of opportunities. I recommend a long trade sized for income exposure with a $38.00 …
GFL trades at ~$39.70 with a $14.3B market cap and an EV of roughly $20.0B. Recent M&A and a modest dividend bump have reignited interest; a rumored $50 takeout would accelerate gains, but the underlying investment case rests on integration-driven margin expansion and a path to stronger free cash flow. This is a medium-risk swing trade that targets…
AKITA Drilling completed a major capacity expansion and is trading at a $142M market cap near $2.55. With utilization likely to rise, technical momentum turning constructive, and outsized short activity creating a squeeze vector, a disciplined long trade targeting $4.25 over a 180 trading day horizon offers a favorable risk/reward. Manage position …
Trekor Metals (TGB) is transitioning from developer to producer. Florence Copper has delivered initial cathodes and Gibraltar delivered steady output in 2025, creating a multi-asset producer in North America. At a $2.74B market cap and improving operational momentum, I am initiating my first-ever Strong Buy on TGB. This trade idea gives an entry at…
WEG SA (WEGZY) trades at $8.92 with a $39.6B market cap and a 3.3% dividend yield. Technicals are constructive and short interest is light. Given accelerating demand for electric motors, transformers and related components across marine, utility and industrial electrification, WEG's per-project content should rise. We view the ADR as an asymmetric …
Trinity (TRN) has quietly become more of a leasing business: steady rental cashflows, a large owned fleet and improving leasing metrics are offsetting cyclical weakness in new car builds. At roughly $3.0B market cap and a PE near 12, the stock offers asymmetric upside if the company converts lease growth into positive free cash flow and begins to c…
Vistra (VST) owns a diverse generation fleet and has locked in long-term deals with hyperscalers, putting it in the crosshairs of the AI data-center power boom. The company generates meaningful free cash flow and carries a valuation that prices in growth; this trade buys the thesis on near-term weakness with a defined stop and a multi-month horizon…
Popular (BPOP) combines above-average free cash flow, low leverage and steady dividend payments. At about $171.70 per share and a market cap near $11.0B, the stock trades at ~12x earnings and ~1.7x book. With free cash flow of $716M and a lean debt profile, Popular has the optionality to accelerate buybacks or hike dividends if higher-for-longer ra…
SLB is trading at $52.45 with a market cap near $79B and free cash flow of roughly $4.7B. Recent data-center and digital revenue acceleration, plus a deepwater FID backlog, should lift margins and organic growth into 2027. We lay out an entry at $52.45, stop at $45.00 and a target at $72.00 over a 180-trading-day horizon, with clear catalysts and r…
Esquire Financial (ESQ) is a compact, profitable regional bank serving the legal industry and small business clients. With trailing EPS at $5.97, ROE at 17% and $61M in free cash flow, the stock offers a clear earnings story while a planned merger with Signature Bancorporation and continued dividend increases create visible catalysts. Technicals ar…
Lumine Group (LMGIF) is a communications and media software consolidator with a $3.82B market cap, a history of M&A-led growth, and a large public float. Technicals are soft but fundamentals and a still-elevated short interest make this a tradeable asymmetric long for investors comfortable with execution risk. Entry, stop and target laid out for a …
Charter is trading at distressed multiples despite generating roughly $4.36B in free cash flow and posting one of the cheapest P/Es in the market. The setup favors disciplined buying on weakness: the business remains cash-generative, broadband is sticky, and sector-level catalysts (Comcast carve-out, SpaceX discussions) could re-rate the stock. Hig…
AvePoint (AVPT) is a SaaS data-management and governance play positioned to benefit from AI-driven demand for secure collaboration. The balance sheet and free cash flow profile support continued reinvestment while valuation metrics and a sub-$13 entry present a favorable risk/reward for a mid-term trade.
Okeanis Eco Tankers (OET) offers a leveraged way to play continued strength in product tanker spot rates. The company's modern, eco-minded fleet and high utilization give it near-term earnings power that can translate into outsized returns over the next 45 trading days. Initiate a long at $6.00 with a $9.00 target and a $4.50 stop — the setup favor…
Okta's Q1 beat and updated FY27 guide reposition the company as a critical identity platform for the 'agentic' AI era. The stock has already rallied from its April lows, but fundamentals (revenue growth, cash flow) and reasonable enterprise multiples leave room for further upside. This trade recommends entering on a measured pullback and holding th…
Novo Nordisk faces near-term headline risk but the company’s GLP-1 franchise and scalable manufacturing give upside that looks priced for risk. Initiating a buy with an entry at $95.00, stop at $85.00 and primary target of $125.00 over a 180-trading-day horizon.
I previously downgraded Super Micro Computer (SMCI). New evidence on order flow, inventory digestion across the channel, and product mix suggests a higher-probability trade to the long side. This is a tactical swing trade with defined entry, stop and target and a clear set of catalysts and risks.
Spotify is a buy-the-dip swing trade. The company's ambitious 'North Star' goals (1B subscribers, $100B revenue, >40% gross margin by 2030), reasonable current valuation relative to long-term targets, and constructive technicals support a long entry at $470.00, a stop at $435.00, and a target of $650.00 over the next 45 trading days—provided Spotif…
International Petroleum (IPCFF) looks set for a mid-term rebound. The stock trades near $22.46 with a $2.62B market cap, reasonable book multiple and high short interest that can amplify directional moves. This trade idea lays out an actionable entry, stop, targets, catalysts and risk plan for a 45-trading-day swing.
Celldex (CLDX) looks actionable as a 'Strong Buy' into Phase 3 topline for barzolvolimab in chronic spontaneous urticaria (CSU). Phase 2 durable, off-treatment responses, accelerated Phase 3 enrollment and a fresh $345M financing de-risk near-term liquidity and commercial readiness. We lay out an entry, stop, and target tied to the Q4 2026 readouts…
